Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06771739 | NOT YET RECRUITING | Malignant Solid Neoplasm

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Sponsor:

Fred Hutchinson Cancer Center

Brief Summary:

This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt and financial hardships for the patient and family. Financial hardship during cancer treatment is associated with adverse outcomes including poorer quality of life, lower treatment compliance, more aggressive use of hospital-based care, and worse survival. Newly diagnosed cancer patients with financial concerns may avoid treatment entirely so that they can continue to work and maintain income, provide for their families, or pay rent. An unrestricted cash payment program provides patients with a preloaded cash card once monthly. The patients can choose what to use the card to pay for and may include items like food, rent, or utilities. This provides a period of guaranteed income for the patients and may prevent them from falling into poverty and improve financial and clinical outcomes.

Condition or disease

Malignant Solid Neoplasm

Intervention/treatment

Electronic Health Record Review

Interview

Support

Support

Survey Administration

Phase

NA

Detailed Description:

OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients receive a $1000 preloaded cash card once monthly for 3 months. ARM B: Patients receive a $100 preloaded cash card once monthly for 3 months. After completion of study intervention, patients are followed up 3 months and 6 months post randomization.

Study Type : INTERVENTIONAL
Estimated Enrollment : 20 participants
Masking : NONE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Preventing Financial Adversity Among Early-Stage Cancer Patients Through Unrestricted Cash (PAYMENT) Pilot Study
Actual Study Start Date : 2025-05-01
Estimated Primary Completion Date : 2025-07-31
Estimated Study Completion Date : 2025-07-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Age \>= 18
  • * Ability to understand English
  • * Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants
  • * Within 90 days of a non-metastatic or early-stage solid tumor receiving or rescheduled to receive treatment in the neoadjuvant, adjuvant or definitive setting for curative intent. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
  • * Current cancer patient at PeaceHealth (Southwest Medical Center or St. Joes)
  • * Not current Medicaid enrollee
  • * Not enrolled in hospice
  • * Screens positive for financial fragility
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Location Details

NCT06771739

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

United States, Washington

PeaceHealth Saint Joseph Medical Center

Bellingham, Washington, United States, 98225

Not yet recruiting

United States, Washington

PeaceHealth Southwest Medical Center

Vancouver, Washington, United States, 98664